Data / Form D filings / Acta Pharmaceuticals, Inc.
Acta Pharmaceuticals, Inc.: Form D filings
Acta Pharmaceuticals, Inc., a pharmaceuticals company in Boston, MA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on April 22, 2024, reports $13.4 million sold of a $17.5 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 292 NEWBURY STREET, Boston, MA, 02115
- Phone
- (857) 930-2282
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1972861
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | Amendment | $17,500,000 | $13,400,781 | $4,099,219 | 29 | Mar 29, 2023 | sec.gov |
| Apr 7, 2023 | New notice | $10,000,000 | $5,049,912 | $4,950,088 | 16 | Mar 29, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George Alex | Executive Officer, Director | |
| Thierry Porte | Director | |
| Rudolph Tanzi | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Apr 22, 2024 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Acta Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.